Vimta Labs share news, announcements and annual reports
NSE: VIMTALABSBSE: 524394Healthcare ServicesSmall Cap
Vimta Labs Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Dec 2005 on NSE
Last close ₹484.90down ₹34.90 (6.71%)BSE ₹484.85
Share price at the NSE close on 30 Oct 2026. Previous close ₹519.80.
30 Oct: open ₹519.90, high ₹522.50, low ₹480.35
52-week range of traded prices to 30 Oct 2026
₹376.05Low, 30 Mar 2026₹735.00High, 3 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹2,167 Cr1,128th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 26.97
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.41%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,41,24221.5% delivered
Vimta Labs board and management
38 filed, newest first.
May 2026
6 May · Management
Jun 2025
Apr 2025
28 Apr · Management
Mar 2025
Jan 2025
Dec 2024
May 2024
18 May · Management
Jan 2024
31 Jan · Management
May 2023
3 May · Management
Jun 2022
May 2022
12 May · Management
May 2021
14 May · Management
Feb 2021
Jan 2021
Aug 2020
Jun 2020
15 Jun · Management
Mar 2019
Jan 2019
Dec 2017
Oct 2017
Sep 2017
27 Sep · Management
Aug 2017
17 Aug · Management
Jul 2016
Jul 2015
May 2015
Jul 2014
May 2013
31 May · Management
Dr. Subba Rao Pavuluri and Dr Rao P Potharlanka were reappointed as Directors by the members in Annual General Meeting held on May 31, 2013.
Mar 2013
Jan 2012
30 Jan · Management
Shri Rao Purnachandra Potharlanka, US national, was appointed as Additional Director by the Board in its meeting held on January 30, 2012.
Apr 2009
30 Apr · Management
Auditor's Report in respect of the audited financial results for the year ended March 31, 2009. A copy of the Auditor's Report shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2008
21 Apr · Management
Auditor's report in respect of the audited financial results for the year ended March 31, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
13 Aug · Management
Shri S Subrahmanyan, Director retiring by rotation at the Annual General Meeting held on August 9, 2007 has opted for not to be reappointed due to his personal reasons. Accordingly he has not been appointed. Further the Company has informed that the following Directors were appointed by the members in Annual General Meeting (1) Dr Subba Rao Pavuluri : re-elected as Director (2) Prof K Ramachandran : as Director
Jun 2007
29 Jun · Management
Prof K Ramachandran was appointed as Additional Director by the Board in its meeting held on 28.06.2007